ArticleMethods in molecular biology (Clifton, N.J.)2025
Gelatin Zymography: Detecting Gelatinase Activity as a Partner for Invadopodia-Mediated Invasion by Tumor Cells.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reconstructing the glioblastoma microenvironment in heterotypic 3D spheroids: a multicellular model to study tumor-stromal crosstalk.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zymography is a technique for detecting, identifying, and quantifying enzyme activity through gel electrophoresis. Gelatin zymography is used to detect matrix metalloproteinase (MMP) activity (a class of zinc-dependent endopeptidases) such as MMP-2 and MMP-9. We describe a semiquantitative method, optimized for determining the activity of secreted gelatinases in cell culture conditioned medium via the digestion of gelatin embedded in a polyacrylamide gel. This assay can also be partnered with a quantitative "invadopodia degradation" assay, which detects the degradation of FITC-labelled gelatin by actin-rich membrane protrusions known as invadopodia. These projections are enriched in proteolytic enzymes, including MMP-2 and MMP-9 in glioblastoma cells, and are secreted to modify/degrade ECM proteins and facilitate tumor cell invasion.
Indexed as
Identifiers
40261631What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.